Human immunodeficiency viruses and drug therapy: Resistance and implications for antiretroviral therapy

Pharmacotherapy

Volumn 22, Issue 5, 2002, Pages 659-662

  Idemyor, Vincent ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; AMPRENAVIR; ANTIRETROVIRUS AGENT; DIDANOSINE; EFAVIRENZ; EMIVIRINE; EMTRICITABINE; ENFUVIRTIDE; INDINAVIR; LAMIVUDINE; LOPINAVIR; NELFINAVIR; NEVIRAPINE; NUCLEOSIDE ANALOG; PROTEINASE INHIBITOR; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAQUINAVIR; STAVUDINE; T 1249; TENOFOVIR; TIPRANAVIR; ZALCITABINE; ZIDOVUDINE;

ANTIVIRAL ACTIVITY; CROSS RESISTANCE; GENE MUTATION; GENETIC CODE; GENETIC VARIABILITY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; PHENOTYPE; REVIEW; VIRAL GENETICS; VIRUS GENOME; VIRUS REPLICATION; VIRUS RESISTANCE;

EID: 0036234480     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.22.8.659.33215     Document Type: Review

References (11)

1. Genetic diversity and evolution of retroviruses
2. Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase
3. Dynamics of HIV-1 replication in vivo
4. The emerging genetic diversity of HIV-the importance of global surveillance for diagnostics, research, and prevention
5. Epidemiology and transmission of HIV-2-why there is no HIV-2 pandemic
6. Detection of diverse variants of human immunodeficiency virus-1 groups M, N, and O and simian immunodeficiency viruses from chimpanzees by using generic pol and env primer pairs
7. Diversite genetique de I'infection a VIH dans le monde et ses consequences
8. Rational approaches to resistance: Nucleoside analogues
9. In vivo emergence of HIV-1 variants resistance to multiple protease inhibitors
10. Prevalence of mutations associated with antiretroviral drug resistance among HIV-1 infected persons in 10 U.S. cities, 1997-2000
11. New insights into mechanisms of HIV-1 resistance to reverse transcriptase inhibitors